CGT Global introduces Clinical Commercial Solutions Guide including Clinical Donor Screening

By vilianayuv | January 16, 2023

  StemExpress introduces Clinical Commercial Solutions Guide including Clinical Donor Screening By StemExpress January 16, 2023 StemExpress has published its full Clinical Commercial Solutions Guide and launched their new Clinical Donor Screening services.  Now, researchers and therapeutic developers can discover how StemExpress is utilizing a nationwide & coast-to-coast footprint of privately owned and operated collection facilities to support the…

For More Information

CGT Global Launches CellsExpress Bulk Cell Isolation

By vilianayuv | January 11, 2023

StemExpress Launches CellsExpress Bulk Cell Isolation Researchers can maximize their isolated cell output, saving valuable time and budget better spent on their research. FOLSOM, Calif. , /PRNewswire/ — As a trusted provider of high-quality isolated human stem and immune cells for over a decade, StemExpress is now proud to offer select isolated products in bulk…

For More Information

2022 Advanced Therapies Week Audiogram

By drivendigital | February 18, 2022

  Live from Phacilitate’s 2022 Advanced Therapies Week in Miami, Florida Take a moment to watch the audiogram of Cate Dyer, CEO & Founder of StemExpress, speak on the importance of partnerships in cell therapy at Phacilitate’s 2022 Advanced Therapies Week.   Picking the Right Partner from Product and Process Development Through Commercialization Qualifying how…

For More Information

Biocom California Member Spotlight

By drivendigital | February 18, 2022

Biocom California recently sat down with Cate Dyer, CEO & Founder of StemExpress to hear what it took to bring her vision to life and how the company built an end-to-end COVID-19 testing solution in a matter of weeks from the very beginning of the pandemic. The article discusses (1) the roots of StemExpress, (2)…

For More Information